Celltrion Pharm Conducts Cheongju Plant Tour for Experts

Celltrion Pharm announced on the 25th that it conducted a tour of the prefilled syringe (PFS) production facility at its Cheongju plant for domestic and international pharmaceutical and bio experts as a pre-event of the '2022 PDA Conference' hosted by the international Parenteral Drug Association (PDA). (Photo by Celltrion Pharm)

[Asia Economy Reporter Chunhee Lee] Celltrion Pharm announced on the 25th that on the 24th, as a pre-event of the ’2022 PDA Biopharmaceutical Aseptic Processing Conference (2022 PDA Conference)’ hosted by the international Parenteral Drug Association (PDA), it conducted a tour of the prefilled syringe (PFS) production facility at its Cheongju plant for domestic and international pharmaceutical and bio experts.

During this tour, Celltrion Pharm introduced the entire PFS production process to the participating experts, highlighting its competitiveness as a global GMP facility. The introduced PFS production line is a three-story building with a total floor area of 2,315㎡. It is capable of producing all processes from preparation, filling, foreign matter inspection, assembly, to packaging. Based on the core process of filling, it can produce up to 19 million syringes annually. In terms of product types, it can produce a total of three types of subcutaneous (SC) finished dosage forms: one pen (auto-injector) type and two prefilled syringe types.

In particular, it was explained that the facility has the advantage of being able to simultaneously produce the pen type and prefilled syringe-S (safety device) type, which have recently seen high demand due to increased emphasis on safety and convenience. Last year, it obtained GMP certification from the European Medicines Agency (EMA), enabling production and supply of export products.

A Celltrion Pharm official said, “This facility tour provided an opportunity to showcase our globally competitive PFS facilities and production capabilities to domestic and international biopharmaceutical experts,” and added, “Following our main business of chemical pharmaceuticals, we will do our best to become a global pharmaceutical production base capable of producing biopharmaceutical finished products based on the competitiveness of our PFS production facilities.”

The 2022 PDA Conference hosted by PDA will be held for two days from the 25th at the Sheraton Grand Hotel in Songdo, Incheon. Domestic and international experts will gather to discuss various topics such as aseptic drug manufacturing, regulations, and quality assurance.

This content was produced with the assistance of AI translation services.